Intermediates caught in the act: Tracing insulin amyloid fibril formation in time by combined optical spectroscopy, light scattering, mass spectrometry and microscopy

Physical Chemistry Chemical Physics

Volumn 17, Issue 2, 2015, Pages 918-927

  Gladytz, A ^a   Lugovoy, E ^a,b   Charvat, A ^a,b   Haupl T ^b   Siefermann, K R ^a   Abel, B ^a,b  

^a LEIBNIZ INSTITUTE OF SURFACE ENGINEERING IOM   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; INSULIN; PROTEIN AGGREGATE;

ANIMAL; BOVINE; CHEMISTRY; LIGHT; MASS SPECTROMETRY; MICROSCOPY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; RADIATION SCATTERING;

AMYLOID; ANIMALS; CATTLE; INSULIN; LIGHT; MASS SPECTROMETRY; MICROSCOPY; PROTEIN AGGREGATES; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; SCATTERING, RADIATION;

EID: 84916618826     PISSN: 14639076     EISSN: None     Source Type: Journal    
DOI: 10.1039/c4cp03072a     Document Type: Article

References (43)

1. C. M. Dobson, Protein folding and misfolding, Nature, 2003, 426, 884.
2. S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science, 1982, 216, 136-144.
3. J. W. Kelly, Mechanisms of amyloidogenesis, Nat. Struct. Biol., 2000, 7, 824-826.
4. A. Ahmad, I. S. Millett, S. Doniach, V. N. Uversky and A. L. Fink, Partially folded intermediates in insulin fibrillation, Biochemistry, 2003, 42, 11404-11416.
5. L. Nielsen, S. Frokjaer, J. Brange, V. N. Uversky and A. L. Fink, Probing the mechanism of insulin fibril formation with insulin mutants, Biochemistry, 2001, 40, 8397-8409.
6. J. L. Whittingham, D. J. Scott, K. Chance, A. Wilson, J. Finch, J. Brange and G. G. Dodson, Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation, J. Mol. Biol., 2002, 318, 479-490.
7. J. L. Jimenez, E. J. Nettleton, M. Bouchard, C. V. Robinson, C. M. Dobson and H. R. Saibil, The protofilament structure of insulin amyloid fibrils, Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 9196-9201.
8. J. Brange, L. Andersen, E. Laursen, G. Mayn and E. Rasmussen, Toward understanding insulin fibrillation, J. Pharm. Sci., 1997, 86, 517.
9. Q.-X. Hua and M. A. Weiss, Mechanismof insulin fibrillation, J. Biol. Chem., 2004, 279, 21449-21460.
10. I. Langmuir and D. F. Waugh, Pressure-soluble and pressure-displaceable components of monolayers of native and denatured proteins, J. Am. Chem. Soc., 1940, 62, 2771-2793.
11. D. F. Waugh, A fibrous modification of insilin. I. The heat precipitate of insulin, J. Am. Chem. Soc., 1946, 68, 247-250.
12. D. F. Waugh, A mechanism for the formation of fibrils from protein molecules, J. Cell. Physiol., 1957, 49, 145-164.
13. M. Groenning, S. Frokjaer and B. Vestergaard, Formation mechsnism of insulin fibrils and structural aspects of the insulin fibrillation process, Curr. Protein Pept. Sci., 2009, 10, 509-528.
14. F. E. Dische, C. Wernstedt, G. T. Westermark, P. Westermark, M. B. Pepys and J. A. Rennie, Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient, Diabetologia, 1988, 31, 158-161.
15. X. Chang, A. M. Jorgensen, P. Bardrum and J. J. Led, Solution structures of the R6 human insulin hexamer, Biochemistry, 1997, 36, 9409-9422.
16. V. Sluzky, J. A. Tamada, A. M. Llibanov and R. Langer, Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces, Proc. Natl. Acad. Sci. U. S. A., 1991, 88, 9377-9381.
17. R. Jansen, W. Dzwolak and R. Winter, Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy, Biophys. J., 2005, 88, 1344-1353.
18. S. Ohnishi and K. Takano, Amyloid fibrils fromthe viewpoint of protein folding, Cell. Mol. Life Sci., 2004, 61, 511-524.
19. T. R. Serio, A. G. Cashikar, A. S. Kowal, G. J. Sawicki, J. J. Moslehi and L. Serpell, Nucleated conformational conversion and the replication of conformational information by a prion determinant, Science, 2000, 289, 1317-1321.
20. D. Eisenberg, R. Nelson, M. R. Sawaya, M. Balbirnie, S. Sambashivan, M. I. Ivanova, A. Madsen and C. Riekel, The structural biology of protein aggregation diseases: Fundamental questions and some answers, Acc. Chem. Res., 2006, 39, 568-575.
21. A. Alzheimer, Über eine eigenartige erkrankung der Hirnrinde, Allg. Z. Psychiatr. Psych.-Gerichtl. Med., 1907, 64, 146-148.
22. S. T. Ferreira, M. N. Vieira and F. G. De Felice, Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases, IUBMB Life, 2007, 59, 332-345.
23. E. J. Nettleton, P. Tito, M. Sunde, M. Bouchard, C. M. Dobson and C. V. Robinson, Characterization of the oligomeric states of insulin in self-assembly and amyloid formation by mass spectrometry, Biophys. J., 2000, 79, 1053-1065.
24. L. F. Pease, M. Sorci, S. Guha, D. H. Tsai, M. R. Zachariah and M. J. Tarlov, Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis, Biophys. J., 2010, 99, 3979-3985.
25. Q. X. Hua and M. A. Weiss, Mechanisms of insulin fibrillation: the structure of insilin under amyloidogenic conditions resembles a protein-folding intermediate, J. Biol. Chem., 2004, 279, 21449-21460.
26. Z. Bumagina, B. Gurvits, N. Artemova, K. Muranov and B. Kurganov, Paradoxical acceleration of dithiothreitol-induced aggregation of insulin in the presence of a chaperone, Int. J. Mol. Sci., 2010, 11, 4556-4579.
27. M. Manno, E. F. Craparo, A. Podesta, D. Bulone, R. Carrotta and V. Martorana, Kinetics of different processes in human insulin amyloid formation, J. Mol. Biol., 2007, 366, 258-274.
28. A. Nayak, M. Sorci, S. Krueger and G. Belfort, A universal pathway for amyloid nucleus and precursor formation for insulin, Proteins, 2009, 74, 556-565.
29. B. Vestergaard, M. Groenning, M. Roessle, J. S. Kastrup, M. van de Weert and J. M. Flink, A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils, PLoS Biol., 2007, 5, e134.
30. M. Sorci, R. A. Grassucci, I. Hahn, J. Frank and G. Belfort, Time-dependent insulin oligomer reaction pathway prior to fibril formation:cooling and seeding, Proteins, 2009, 77, 62-73.
31. A. Podestra, G. Tiana, P. Milani and M. Manno, Early events in insulin fibrilisation studied by time-lapse atomic force microscopy, Biophys. J., 2006, 90, 589-597.
32. J. Haas, E. Vohringer-Martinez, A. Bogehold, D. Matthes, U. Hensen, A. Pelah, B. Abel and H. Grubmuller, Primary steps of pH-dependent insulin aggregation kinetics are governed by conformational flexibility, ChemBioChem, 2009, 10, 1816-1822.
33. A. Veltova, M. Tatarek-Nossol, E. Andreetto and A. Kapurniotu, Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: Nanomolar affinity inhibition of insulin aggregation by an IAPP mimic, Angew. Chem., Int. Ed., 2008, 47, 7114-7118.
34. B. Abel, A. Charvat, U. Diederichsen, M. Faubel, B. Grimann, J. Niemeyer and A. Zeeck, Applications, features, and mechanistic aspects of liquid water beam desorption mass spectrometry, Int. J. Mass Spectrom., 2005, 243, 177-188.
35. A. Charvat, E. Lugovoj, M. Faubel and B. Abel, Analytical laser induced liquid beam desorption mass spectrometry of protonated amio acids and their non-covalently bound aggregates, Eur. Phys. J. D, 2002, 20, 573.
36. A. Charvat, E. Lugovoj, M. Faubel and B. Abel, New design for a time-of-flight mass spectrometer, Rev. Sci. Instrum., 2004, 75, 1209-1218.
37. M. Faubel, Advanced Series in Physical Chemistry, in Photoelectron spectroscopy at liquid surfaces, ed. C. Y. Ng, World Scientific, New York, 2000, vol. 10A.
38. M. Faubel and T. Kisters, Non-equilibrium molecular evaporation of carboxylic acid dimers, Nature, 1989, 339, 527-529.
39. P. Guttmann, G. Schmahl, B. Niemann, D. Rudoph, G. Schneider and J. Bahrdt, The X-Ray Microscopy project at BESSY II, in X-Ray Microscopy and Spectromicroscopy, ed. J. Thieme, G. Schmahl, D. Rudoph and E. Umbach, Springer, Berlin-Heidelberg, 1998, ISBN: 3-540-63998-5.
40. A. Charvat and B. Abel, How to make big molecules fly out of liquid water: applications, features and physics of laser assisted liquid phase dispersion mass spectrometry, Phys. Chem. Chem. Phys., 2007, 9, 3335-3360.
41. M. Eigen, Prionics or the kinetic basis of prion diseases, Biophys. Chem., 1996, 63, A1-A18.
42. C. L. Heldt, D. Kurouski, M. Sorci, E. Grafeld, I. K. Lednev and G. Belfort, Isolating toxic insulin amyloid reactive species that lack beta-sheetsand have a wide pH-Stability, Biophys. J., 2011, 100, 2792-2800.
43. V. Foderà, F. Librizzi, M. Groenning, M. van de Weert and M. Leone, Secondary Nucleation and Accessible Surface in Insulin Amyloid Fibril Formation, J. Phys. Chem. B, 2008, 112, 3853-3858.